The global blood culture tests market is projected to reach USD 6.1 billion by 2025 from USD 4.0 billion in 2020, at a CAGR of 8.9%. Growth in this market is mainly driven by the increasing number of sepsis cases and high cost of treatment, rising geriatric population, high incidence of bloodstream infections, growth in the demand for rapid diagnostic techniques, and the high prevalence of infectious diseases.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=159606753
Blood culture tests involve taking a small sample of blood from the patient and incubating it in a specialized culture medium that promotes the growth of microorganisms. If there are any pathogens present in the blood, they will multiply and can be identified through various techniques, such as microscopy, biochemical tests, or molecular methods.
Technological advancements in blood culture testing have further fueled market growth. Automated blood culture systems, which can rapidly detect the presence of pathogens and provide detailed information about their susceptibility to antimicrobial drugs, have gained popularity. These systems offer faster turnaround times, improved sensitivity, and enhanced accuracy compared to traditional manual methods.
Geographically, North America and Europe have traditionally been the largest markets for blood culture tests due to well-established healthcare infrastructure and high awareness levels. However, the market is also expanding in emerging economies in Asia Pacific, Latin America, and the Middle East as healthcare systems improve and there is a greater focus on infectious disease management.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.prnewswire.com/news-releases/blood-culture-tests-market-worth-6-1-billion-by-2025--exclusive-report-by-marketsandmarkets-301219967.html
Key Market Players
Major players operating in the blood culture tests market include Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India).
Report Objectives
- To define, describe, and measure the blood culture tests market by method, product, technology, application, end user and region
- To provide detailed information about the major factors influencing market growth (such as drivers, restraints, growth opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the blood culture tests market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market in North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa
- To strategically analyze the market structure and profile key players and their core competencies3 in the blood culture tests market
- To track and analyze competitive developments such as product launches, expansions, acquisitions, and partnerships collaborations in the blood culture tests market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present blood culture tests market report:
Product Analysis
Product Matrix, which gives a detailed comparison of the product portfolio of each company (Top 3 companies)
Company Information
Detailed analysis and profiling of additional market players (up to 3)
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=159606753
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
